ConductScience.org, home

Paper209809

Peripheral neuropathy related to misonidazole: incidence and pathology.

Urtasun RC and 8 others. Br J Cancer Suppl, 1978. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. Peripheral neuropathy related to misonidazole: incidence and pathology. Papers, record 209809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/209809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peripheral neuropathy related to misonidazole: incidence and pathology.
PubMed
Journal
Br J Cancer Suppl
PubMed
Year
1978
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.27
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Urtasun RCR C
2Chapman JDJ D
3Feldstein MLM L
4Band RPR P
5Rabin HRH R
6Wilson AFA F
7Marynowski BB
8Starreveld EE
9Shnitka TT

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NitroimidazolesMajor topic
Peripheral Nervous System DiseasesMajor topic
Radiation-Sensitizing AgentsMajor topic
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasms
Neural Conduction
Sural Nerve

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1861146Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.Br J Cancer1977https://conductscience.org/library/papers/861146PubMed
2841074Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.Radiology1977https://conductscience.org/library/papers/841074PubMed
34357490Peripheral neuropathy caused by chemical agents.CRC Crit Rev Toxicol1973https://conductscience.org/library/papers/4357490PubMed
459040Letter: Metronidazole and tissue zinc/iron ratio in cancer therapy.Lancet1976https://conductscience.org/library/papers/59040PubMed
54830160Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials.Br J Radiol1974https://conductscience.org/library/papers/4830160PubMed
6776493Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.Clin Radiol1976https://conductscience.org/library/papers/776493PubMed

Download CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
38880855Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts.Invest New Drugs2024https://conductscience.org/library/papers/38880855PubMed
36522715Correlation of magnetic resonance images with neuropathology of irreversible metronidazole-induced encephalopathy: an autopsy case report.BMC Neurol2022https://conductscience.org/library/papers/36522715PubMed
33603370Application of Radiosensitizers in Cancer Radiotherapy.Int J Nanomedicine2021https://conductscience.org/library/papers/33603370PubMed
32899427Radioresistance in Glioblastoma and the Development of Radiosensitizers.Cancers (Basel)2020https://conductscience.org/library/papers/32899427PubMed
27318945Emerging targets for radioprotection and radiosensitization in radiotherapy.Tumour Biol2016https://conductscience.org/library/papers/27318945PubMed
20563257The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.Transl Oncol2010https://conductscience.org/library/papers/20563257PubMed
19138031Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.Radiat Res2008https://conductscience.org/library/papers/19138031PubMed
7460192Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7460192PubMed
7387850Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.Br J Cancer1980https://conductscience.org/library/papers/7387850PubMed
7370170Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.Br J Cancer1980https://conductscience.org/library/papers/7370170PubMed
7295516Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.Br J Cancer1981https://conductscience.org/library/papers/7295516PubMed
7273265Structure-pharmacokinetic relationships for misonidazole analogues in mice.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7273265PubMed
7104192In vivo assessment of basic 2-nitroimidazole radiosensitizers.Br J Cancer1982https://conductscience.org/library/papers/7104192PubMed
7067719Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/7067719PubMed
6890846Hypoxic cell sensitization to radiation damage by a new radiosensitizer: cis-dichloro-bis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole-N3)platinum(II) (flap).Br J Cancer1982https://conductscience.org/library/papers/6890846PubMed
6678963Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.J Neurooncol1983https://conductscience.org/library/papers/6678963PubMed
6626454The role of dexamethasone in the modification of misonidazole pharmacokinetics.Br J Cancer1983https://conductscience.org/library/papers/6626454PubMed
6481429Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat.J Neurooncol1984https://conductscience.org/library/papers/6481429PubMed
6481428Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials.J Neurooncol1984https://conductscience.org/library/papers/6481428PubMed
6285947Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.Br J Cancer1982https://conductscience.org/library/papers/6285947PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/209809

GET https://conductscience.org/api/papers/v1/209809/cited_by?page=2